Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25464313 | 0.70 | CA12 (0.37) | — | |
| SCHEMBL24768401 | 0.67 | — | — | |
| SCHEMBL25464305 | 0.66 | — | — | |
| SCHEMBL1106092 | 0.64 | NPC1 (0.31) | — | |
| SCHEMBL16599741 | 0.63 | GLRA3 (0.31) | — | |
| SCHEMBL22140330 | 0.63 | NPC1 (0.36) | — | |
| SCHEMBL11941344 | 0.60 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL1106198 | 0.60 | NPC1 (0.33) | — | |
| SCHEMBL18431502 | 0.59 | — | — | |
| SCHEMBL5021097 | 0.59 | CDK1 (0.38) | PDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702422-B2 | Imidazopyridazines as modulators of IL-17 | JANSSEN PHARMACEUTICA NV (BE) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702422-B2 | Imidazopyridazines as modulators of IL-17 | IL17A, IL23R, IL15 | PDE3B 419/4885PDE3A 499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.